<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F3AF47FC-52EA-49D6-8520-F63D45185E65"><gtr:id>F3AF47FC-52EA-49D6-8520-F63D45185E65</gtr:id><gtr:firstName>Cay</gtr:firstName><gtr:surname>Kielty</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700712"><gtr:id>3F9C5A72-A3B6-4321-A167-AB377382D883</gtr:id><gtr:title>Regulation of mesenchymal stem cells during vascular remodelling by platelet-derived growth factor receptor-alpha.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700712</gtr:grantReference><gtr:abstractText>Our research will be presented orally at scientific meetings and conferences, and in peer-reviewed research papers, review-type articles. We will publish articles in magazines and newsletters aimed at biotechnology and healthcare industries. 
A likely avenue for lay reporting will be communicating with school students as part of our outreach programmes in which students visit the host laboratory, or through the Manchester Museum, which organises regular science days. Our laboratory regularly hosts work experience students.</gtr:abstractText><gtr:technicalSummary>Mesenchymal stem cells in bone marrow and perivascular niches act as a source of multipotential cells for tissue regeneration. We have discovered that, in bone marrow-derived MSC, vascular endothelial growth factor-A activates platelet-derived growth factor receptors which, in turn, regulate migration, proliferation and vascular differentiation. We also have evidence for the involvement of neuropilin-1, beta1 integrins and vascular extracellular matrix in platelet-derived growth factor receptor activation. Building on these advances, this proposal is to study ligand-specific platelet-derived growth factor receptor-alpha signalling in mesenchymal stem cells, and its role in vascular remodelling.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>641473</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigation of PDGF receptor interactions with neuropilin-1.</gtr:description><gtr:id>532985B7-E939-41EB-A8E7-24F16FA9C2FC</gtr:id><gtr:impact>I was an invited speaker at the Biochemical Society international meeting on Angiogenesis at the University of Chester meeting, in July 2009. My PhD student presented a poster.</gtr:impact><gtr:outcomeId>733C02687D1-1</gtr:outcomeId><gtr:partnerContribution>CASE PhD studentship (AZ provided reagents to assist in analysing PDGF receptor interactions with neuropilin-1).</gtr:partnerContribution><gtr:piContribution>I am PhD supervisor and I wrote the PhD proposal.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminars at UK Institutions</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACA6AEFF-5E27-48CE-B1BE-2DE1DD57C473</gtr:id><gtr:impact>Kings College London (Denmark Hill Campus; vascular tissue engineering)
Manchester (Biochem Soc meeting; elastic fibres)
Bristol University (elastic fibres)
Edinburgh University (progenitor cells)
Keele University (vascular tissue engineering)
Newcastle University (progenitor cells)
Birmingham University (progenitor cells)

Collaborative links.</gtr:impact><gtr:outcomeId>194CD042487</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK National Stem Cell Network (UKNSCN) meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AB163E0D-01BC-4443-8CEB-A63D4DD9F9F4</gtr:id><gtr:impact>April 2008. Edinburgh. Invited speaker. April 2009. Workshop leader (Mesenchymal Stem Cells)

New collaborative links.</gtr:impact><gtr:outcomeId>C579D403E24</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Manchester Musculoskeletal Biomedical Research Unit</gtr:department><gtr:description>Manchester Biomedical Research Centre BRC) Small Grant Scheme</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C42B068B-B124-4FE6-ACA7-997B1189AD55</gtr:id><gtr:outcomeId>0262F8B08980</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2575000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Novel Technologies for Stem Cell Science (co-I)</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EPH046070/1</gtr:fundingRef><gtr:id>6F0C8D14-F5D3-4EFE-900B-C9A5834533C9</gtr:id><gtr:outcomeId>KSzwwvxvB3v</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>1D63703F-AB7E-4188-B91E-BF6842A0210A</gtr:id><gtr:outcomeId>096257F5B070</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>780000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC-BHF Strategic Award</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0902170</gtr:fundingRef><gtr:id>E8FEB717-421B-48DC-998E-569825983690</gtr:id><gtr:outcomeId>HUo6t8jbGUw</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>88E0E660-091E-4457-93E8-7E4C4AE982A0</gtr:id><gtr:outcomeId>jPQNHuS6LbC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>65F61D5D-160C-422F-9824-3FFA79124E38</gtr:id><gtr:outcomeId>82DE63594F30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Inducible Pluripotent Stem Cell Supplement</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5E269731-BB0B-4540-A4FB-538FA1B248C8</gtr:id><gtr:outcomeId>28F03FE8D2E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Preliminary development of small-diameter tissue engineered vascular grafts, incorporating elastic fibre reagents and adult progenitor cells.</gtr:description><gtr:id>C924275E-9CA0-4B20-870F-6F1C5C860DEC</gtr:id><gtr:impact>No translational achievements to date.
Small grant funding from Manchester Biomedical Research Centre for small diameter graft design (&amp;pound;20K). 
The application of extracellular matrix coatings of graft scaffolds - one year contract with Johnson&amp;amp;Johnson (ATRMUS); now closed.</gtr:impact><gtr:outcomeId>182F87B1D07</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Vascular tissue engineering</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Human PDGF receptors alpha and beta knockdown and knock-in vectors (retroviral), mutants, with and without tyrosine signalling mutations. Also, human neuropilin-1 full-length and ectodomain costructs.</gtr:description><gtr:id>DD5C21DD-8672-4ACC-9269-1AA94CE3FED9</gtr:id><gtr:impact>New insights into how the PDGF receptor signalling pathways regulate mesenchymal stem cells.</gtr:impact><gtr:outcomeId>939D8915F73</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PDGF receptor expression vectors</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>53DF18BB-702D-46C7-A3FF-1662E2DCAC1E</gtr:id><gtr:title>Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors.</gtr:title><gtr:parentPublicationTitle>Journal of cellular and molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1582-1838</gtr:issn><gtr:outcomeId>pm_12418_18_17979880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA6B4C46-D2C4-4575-8B54-FC564B4A9A34</gtr:id><gtr:title>Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>Au4GFQdnkbc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>519090DB-B841-4B16-B9A7-F80334FA8230</gtr:id><gtr:title>Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>8F605810E78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB3F6F1E-A413-493D-8EF7-DFB88BA594A5</gtr:id><gtr:title>Density of human bone marrow stromal cells regulates commitment to vascular lineages.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b1dc658aecb40dbb9beea4b3adcf0c7"><gtr:id>1b1dc658aecb40dbb9beea4b3adcf0c7</gtr:id><gtr:otherNames>Whyte JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>EbecWBVvUQV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD3F63A5-B02A-4647-AB1E-F3BF0324E963</gtr:id><gtr:title>Mesenchymal stem cell migration is regulated by fibronectin through a5?1-integrin-mediated activation of PDGFR-? and potentiation of growth factor signals.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01de456f811a8e1632830d551a39633c"><gtr:id>01de456f811a8e1632830d551a39633c</gtr:id><gtr:otherNames>Veevers-Lowe J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>ZWgA5baFE4S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C368EF71-5A43-456B-AFF9-0397C3B13B27</gtr:id><gtr:title>Platelet-derived growth factor receptor-alpha is a key determinant of smooth muscle alpha-actin filaments in bone marrow-derived mesenchymal stem cells.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>D79DFA7AC2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B82B6469-CD8B-4787-AD87-B588AC6D1072</gtr:id><gtr:title>Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_12418_28_22213560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA6C7AAE-1A63-43E5-BE2E-DCB7F088E518</gtr:id><gtr:title>Vascular endothelial growth factor can signal through platelet-derived growth factor receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>D8D9683F5C2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700712</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>